Skip to main content
Erschienen in: Tumor Biology 4/2011

01.08.2011 | Research Article

Telomerase reverse transcriptase catalytic subunit expression and proliferation index in Wilms tumor

verfasst von: Gulden Diniz, Safiye Aktas, Aysen Turedi, Gunyuz Temir, Ragip Ortac, Canan Vergin

Erschienen in: Tumor Biology | Ausgabe 4/2011

Einloggen, um Zugang zu erhalten

Abstract

Telomerase activity provides telomere maintenance in chromosomes. It prevents cells from entering senescence. Telomerase activity is one of the crucial steps in various cancers. Wilms tumor (nephroblastoma) is one of the most common solid tumors of childhood. Hitherto, telomerase reverse transcriptase (TERT) catalytic subunit expression in Wilms tumor has not been investigated widely. The aim of this study was to explore the expression level of human TERT in Wilms tumor and to correlate with some clinical prognosis factors such as tumor weight, stage, histology, and Ki67 expression. This study included 41 nephroblastoma cases of childhood. The telomerase catalytic subunit expression and proliferation index was determined using an immunohistochemical method on archival paraffin-embedded tissue sections. Statistical analysis was done on SPSS 9.05 by Mann–Whitney U test and Spearman’s correlation analysis. TERT expression was negative in 11 cases (26.8%), weakly positive in 14 cases (34.1%), and strongly positive in 16 cases (39%). The proliferation index was found to be 20 to 90 (mean 58.9 ± 26.8). Using Spearman correlation analysis, both the TERT expression (p = 0.032) and Ki67 index (p = 0.048) were found to be correlated with survival rate. Similarly, both the telomerase expression (p = 0.011) and the Ki67 index (0.040) were correlated with the weight and dimension of the tumor. But there was no relationship between telomerase expression and Ki67 index (p = 0.429). The mean survival time for telomerase negative cases was 56.6 ± 27.3 months, while it was 34.67 ± 28.36 months for positive cases. The Mann–Whitney U test revealed that levels of telomerase (p = 0.040) significantly affected the survival rate. In the present study, we showed that the presence of TERT expression correlated with both tumor size and survival time. These findings suggest that senescence may play an important role in WT evolution, and determination of telomere maintenance will be useful to predict survival and follow-up of patients with Wilms tumor.
Literatur
1.
Zurück zum Zitat Shay JW, Zou Y, Hiyama H, Wright WE. Telomerase and cancer. Hum mol genet. 2001;10(7):677–85.PubMedCrossRef Shay JW, Zou Y, Hiyama H, Wright WE. Telomerase and cancer. Hum mol genet. 2001;10(7):677–85.PubMedCrossRef
2.
Zurück zum Zitat Hiyama E, Yamaoka H, Matsunaga T, Hayashi Y, Ando H, Suita S, et al. High expression of telomerase is an independent prognostic indicator of poor outcome in hepatoblastoma. Br J Cancer. 2004;91(5):972–9.PubMed Hiyama E, Yamaoka H, Matsunaga T, Hayashi Y, Ando H, Suita S, et al. High expression of telomerase is an independent prognostic indicator of poor outcome in hepatoblastoma. Br J Cancer. 2004;91(5):972–9.PubMed
3.
Zurück zum Zitat Cukusić A, Skrobot Vidacek N, Sopta M, Rubelj I. Telomerase regulation at the crossroads of cell fate. Cytogenet Genome Res. 2008;122(3–4):263–72.PubMed Cukusić A, Skrobot Vidacek N, Sopta M, Rubelj I. Telomerase regulation at the crossroads of cell fate. Cytogenet Genome Res. 2008;122(3–4):263–72.PubMed
4.
Zurück zum Zitat Cakir C, Gulluoglu MG, Yilmazbayhan D. Cell proliferation rate and telomerase activity in the differential diagnosis between benign and malignant mesothelial proliferations. Pathology. 2006;38(1):10–5.PubMedCrossRef Cakir C, Gulluoglu MG, Yilmazbayhan D. Cell proliferation rate and telomerase activity in the differential diagnosis between benign and malignant mesothelial proliferations. Pathology. 2006;38(1):10–5.PubMedCrossRef
5.
6.
Zurück zum Zitat Hiyama E, Hiyama K, Yokoyama T, Shay JW. Immunohistochemical detection of telomerase (hTERT) protein in human cancer tissues and a subset of cells in normal tissues. Neoplasia. 2001;3(1):17–26.PubMedCrossRef Hiyama E, Hiyama K, Yokoyama T, Shay JW. Immunohistochemical detection of telomerase (hTERT) protein in human cancer tissues and a subset of cells in normal tissues. Neoplasia. 2001;3(1):17–26.PubMedCrossRef
7.
Zurück zum Zitat Hashimoto Y, Murakami Y, Uemura K, Hayashidani Y, Sudo T, Ohge H, et al. Detection of human telomerase reverse transcriptase (hTERT) expression in tissue and pancreatic juice from pancreatic cancer. Surgery. 2008;143(1):113–25.PubMedCrossRef Hashimoto Y, Murakami Y, Uemura K, Hayashidani Y, Sudo T, Ohge H, et al. Detection of human telomerase reverse transcriptase (hTERT) expression in tissue and pancreatic juice from pancreatic cancer. Surgery. 2008;143(1):113–25.PubMedCrossRef
8.
Zurück zum Zitat Bruey JM, Kantarjian H, Ma W, Estrov Z, Yeh C, Donahue A, et al. Circulating Ki-67 index in plasma as a biomarker and prognostic indicator in chronic lymphocytic leukemia. Leuk Res. 2010;34:1320–4.PubMedCrossRef Bruey JM, Kantarjian H, Ma W, Estrov Z, Yeh C, Donahue A, et al. Circulating Ki-67 index in plasma as a biomarker and prognostic indicator in chronic lymphocytic leukemia. Leuk Res. 2010;34:1320–4.PubMedCrossRef
9.
Zurück zum Zitat Scholzen T, Gerdes J. The Ki-67 protein: from the known and the unknown. J Cell Physiol. 2000;182:311–22.PubMedCrossRef Scholzen T, Gerdes J. The Ki-67 protein: from the known and the unknown. J Cell Physiol. 2000;182:311–22.PubMedCrossRef
10.
Zurück zum Zitat Jurić I, Pogorelić Z, Kuzmić-Prusac I, Biočić M, Jakovljević G, Stepan J, et al. Expression and prognostic value of the Ki-67 in Wilms’ tumor: experience with 48 cases. Pediatr Surg Int. 2010;26:487–93.PubMedCrossRef Jurić I, Pogorelić Z, Kuzmić-Prusac I, Biočić M, Jakovljević G, Stepan J, et al. Expression and prognostic value of the Ki-67 in Wilms’ tumor: experience with 48 cases. Pediatr Surg Int. 2010;26:487–93.PubMedCrossRef
11.
Zurück zum Zitat Scott RH, Walker L, Olsen ØE, Levitt G, Kenney I, Maher E, et al. Surveillance for Wilms tumour in at-risk children: pragmatic recommendations for best practice. Arch Dis Child. 2006;91(12):995–9.PubMedCrossRef Scott RH, Walker L, Olsen ØE, Levitt G, Kenney I, Maher E, et al. Surveillance for Wilms tumour in at-risk children: pragmatic recommendations for best practice. Arch Dis Child. 2006;91(12):995–9.PubMedCrossRef
12.
Zurück zum Zitat Husain AN, Pysher TJ, Dehner LP. The kidney and lower urinary tract. In: Stocker JT, Dehner LP, editors. Pediatric pathology. Philadelphia: Lippincott Williams & Wilkins; 2001. p. 834–903. Husain AN, Pysher TJ, Dehner LP. The kidney and lower urinary tract. In: Stocker JT, Dehner LP, editors. Pediatric pathology. Philadelphia: Lippincott Williams & Wilkins; 2001. p. 834–903.
13.
Zurück zum Zitat Perlman EJ. Renal tumors. In: Gilbert-Barness E, editor. Potter’s pathology of the fetus, infant and child. Philadelphia: Mosby Elsevier; 2007. p. 1347–75. Perlman EJ. Renal tumors. In: Gilbert-Barness E, editor. Potter’s pathology of the fetus, infant and child. Philadelphia: Mosby Elsevier; 2007. p. 1347–75.
14.
Zurück zum Zitat Argani P, Beckwith JB. Renal neoplasms of childhood. In: Mills SE, editor. Sternberg’s diagnostic surgical pathology. Philadelphia: Lippincott Williams and Wilkins; 2004. p. 2001–33. Argani P, Beckwith JB. Renal neoplasms of childhood. In: Mills SE, editor. Sternberg’s diagnostic surgical pathology. Philadelphia: Lippincott Williams and Wilkins; 2004. p. 2001–33.
15.
16.
Zurück zum Zitat Terenziani M, Spreafico F, Collini P, Piva L, Perotti D, Podda M, et al. Adult Wilms’ tumor: a monoinstitutional experience and a review of the literature. Cancer. 2004;101(2):289–93.PubMedCrossRef Terenziani M, Spreafico F, Collini P, Piva L, Perotti D, Podda M, et al. Adult Wilms’ tumor: a monoinstitutional experience and a review of the literature. Cancer. 2004;101(2):289–93.PubMedCrossRef
17.
Zurück zum Zitat Scott RH, Stiller CA, Walker L, Rahman N. Syndromes and constitutional chromosomal abnormalities associated with Wilms tumour. J Med Genet. 2006;43(9):705–15.PubMedCrossRef Scott RH, Stiller CA, Walker L, Rahman N. Syndromes and constitutional chromosomal abnormalities associated with Wilms tumour. J Med Genet. 2006;43(9):705–15.PubMedCrossRef
18.
Zurück zum Zitat Hohenstein P, Hastie ND. The many facets of the Wilms’ tumour gene, WT1. Hum Mol Genet. 2006;15(Spec No 2):R196–201.PubMedCrossRef Hohenstein P, Hastie ND. The many facets of the Wilms’ tumour gene, WT1. Hum Mol Genet. 2006;15(Spec No 2):R196–201.PubMedCrossRef
19.
Zurück zum Zitat Maw MA, Grundy PE, Millow LJ, Eccles MR, Dunn RS, Smith PJ, et al. A third Wilms’ tumor locus on chromosome 16q. Cancer Res. 1992;52(11):3094–8.PubMed Maw MA, Grundy PE, Millow LJ, Eccles MR, Dunn RS, Smith PJ, et al. A third Wilms’ tumor locus on chromosome 16q. Cancer Res. 1992;52(11):3094–8.PubMed
20.
Zurück zum Zitat Rahman N, Arbour L, Tonin P, Renshaw J, Pelletier J, Baruchel S, et al. Evidence for a familial Wilms’ tumour gene (FWT1) on chromosome 17q12–q21. Nat Genet. 1996;13(4):461–3.PubMedCrossRef Rahman N, Arbour L, Tonin P, Renshaw J, Pelletier J, Baruchel S, et al. Evidence for a familial Wilms’ tumour gene (FWT1) on chromosome 17q12–q21. Nat Genet. 1996;13(4):461–3.PubMedCrossRef
21.
Zurück zum Zitat Miozzo M, Perotti D, Minoletti F, Mondini P, Pilotti S, Luksch R, et al. Mapping of a putative tumor suppressor locus to proximal 7p in Wilms tumors. Genomics. 1996;37(3):310–5.PubMedCrossRef Miozzo M, Perotti D, Minoletti F, Mondini P, Pilotti S, Luksch R, et al. Mapping of a putative tumor suppressor locus to proximal 7p in Wilms tumors. Genomics. 1996;37(3):310–5.PubMedCrossRef
22.
Zurück zum Zitat White GR, Kelsey AM, Varley JM, Birch JM. Somatic glypican 3 (GPC3) mutations in Wilms’ tumour. Br J Cancer. 2002;86(12):1920–2.PubMedCrossRef White GR, Kelsey AM, Varley JM, Birch JM. Somatic glypican 3 (GPC3) mutations in Wilms’ tumour. Br J Cancer. 2002;86(12):1920–2.PubMedCrossRef
23.
Zurück zum Zitat Rivera MN, Kim WJ, Wells J, Driscoll DR, Brannigan BW, Han M, et al. An X chromosome gene, WTX, is commonly inactivated in Wilms tumor. Science. 2007;315(5812):642–5.PubMedCrossRef Rivera MN, Kim WJ, Wells J, Driscoll DR, Brannigan BW, Han M, et al. An X chromosome gene, WTX, is commonly inactivated in Wilms tumor. Science. 2007;315(5812):642–5.PubMedCrossRef
24.
Zurück zum Zitat Slade I, Stephens P, Douglas J, Barker K, Stebbings L, Abbaszadeh F, et al. Constitutional translocation breakpoint mapping by genome-wide paired-end sequencing identifies HACE1 as a putative Wilms tumour susceptibility gene. J Med Genet. 2010;47(5):342–7.PubMedCrossRef Slade I, Stephens P, Douglas J, Barker K, Stebbings L, Abbaszadeh F, et al. Constitutional translocation breakpoint mapping by genome-wide paired-end sequencing identifies HACE1 as a putative Wilms tumour susceptibility gene. J Med Genet. 2010;47(5):342–7.PubMedCrossRef
25.
Zurück zum Zitat Ramachandran C, Melnick SJ, Escalon E, Jhabvala P, Khatib Z, Alamo A, et al. Expression of apoptosis, cell proliferation, and drug resistance genes in pediatric Wilms’ tumors. Anticancer Res. 2000;20(5C):3759–65.PubMed Ramachandran C, Melnick SJ, Escalon E, Jhabvala P, Khatib Z, Alamo A, et al. Expression of apoptosis, cell proliferation, and drug resistance genes in pediatric Wilms’ tumors. Anticancer Res. 2000;20(5C):3759–65.PubMed
26.
Zurück zum Zitat Ramburan A, Hadley GP, Govender D. Expression of E-cadherin, cadherin-11, alpha-, beta- and gamma-catenins in nephroblastomas: relationship with clinicopathological parameters, prognostic factors and outcome. Pathology. 2006;38(1):39–44.PubMedCrossRef Ramburan A, Hadley GP, Govender D. Expression of E-cadherin, cadherin-11, alpha-, beta- and gamma-catenins in nephroblastomas: relationship with clinicopathological parameters, prognostic factors and outcome. Pathology. 2006;38(1):39–44.PubMedCrossRef
27.
Zurück zum Zitat Wittmann S, Wunder C, Zirn B, Furtwängler R, Wegert J, Graf N, et al. New prognostic markers revealed by evaluation of genes correlated with clinical parameters in Wilms tumors. Genes Chromosomes Cancer. 2008;47(5):386–95.PubMedCrossRef Wittmann S, Wunder C, Zirn B, Furtwängler R, Wegert J, Graf N, et al. New prognostic markers revealed by evaluation of genes correlated with clinical parameters in Wilms tumors. Genes Chromosomes Cancer. 2008;47(5):386–95.PubMedCrossRef
28.
Zurück zum Zitat Dome JS, Chung S, Bergemann T, Umbricht CB, Saji M, Carey LA, et al. High telomerase reverse transcriptase (hTERT) messenger RNA level correlates with tumor recurrence in patients with favorable histology Wilms’ tumor. Cancer Res. 1999;59(17):4301–7.PubMed Dome JS, Chung S, Bergemann T, Umbricht CB, Saji M, Carey LA, et al. High telomerase reverse transcriptase (hTERT) messenger RNA level correlates with tumor recurrence in patients with favorable histology Wilms’ tumor. Cancer Res. 1999;59(17):4301–7.PubMed
29.
Zurück zum Zitat Dome JS, Bockhold CA, Li SM, Baker SD, Green DM, Perlman EJ, et al. High telomerase RNA expression level is an adverse prognostic factor for favorable-histology Wilms’ tumor. J Clin Oncol. 2005;23(36):9138–45.PubMedCrossRef Dome JS, Bockhold CA, Li SM, Baker SD, Green DM, Perlman EJ, et al. High telomerase RNA expression level is an adverse prognostic factor for favorable-histology Wilms’ tumor. J Clin Oncol. 2005;23(36):9138–45.PubMedCrossRef
30.
Zurück zum Zitat Yashima K, Maitra A, Timmons CF, Rogers BB, Pinar H, Shay JW, et al. Expression of the RNA component of telomerase in Wilms tumor and nephrogenic rest recapitulates renal embryogenesis. Hum Pathol. 1998;29(5):536–42.PubMedCrossRef Yashima K, Maitra A, Timmons CF, Rogers BB, Pinar H, Shay JW, et al. Expression of the RNA component of telomerase in Wilms tumor and nephrogenic rest recapitulates renal embryogenesis. Hum Pathol. 1998;29(5):536–42.PubMedCrossRef
31.
Zurück zum Zitat Green DM, D’Anjio GJ, Beckwith JB. Wilms’ tumor. In: Pizzo PA, Fobcek DG, editors. Principles and practice of pediatric oncology. 2nd ed. Philadelphia: Lippincott; 1997. p. 733–59. Green DM, D’Anjio GJ, Beckwith JB. Wilms’ tumor. In: Pizzo PA, Fobcek DG, editors. Principles and practice of pediatric oncology. 2nd ed. Philadelphia: Lippincott; 1997. p. 733–59.
32.
Zurück zum Zitat Williams G. Statistical methods. In: Detels R, Beaglehole R, Lansung MA, Gulliford M, editors. Oxford textbook of public health: epidemiological and biostatistical approaches, vol. 2. 5th ed. England: Oxford Press; 2009. p. 448–714. Williams G. Statistical methods. In: Detels R, Beaglehole R, Lansung MA, Gulliford M, editors. Oxford textbook of public health: epidemiological and biostatistical approaches, vol. 2. 5th ed. England: Oxford Press; 2009. p. 448–714.
33.
Zurück zum Zitat Horster MF, Braun GS, Huber SM. Embryonic renal epithelia: induction, nephrogenesis, and cell differentiation. Physiol Rev. 1999;79:1157–91.PubMed Horster MF, Braun GS, Huber SM. Embryonic renal epithelia: induction, nephrogenesis, and cell differentiation. Physiol Rev. 1999;79:1157–91.PubMed
34.
Zurück zum Zitat Quaggin SE, Kreidberg JA. Development of the renal glomerulus: good neighbors and good fences. Development. 2008;135(4):609–20.PubMedCrossRef Quaggin SE, Kreidberg JA. Development of the renal glomerulus: good neighbors and good fences. Development. 2008;135(4):609–20.PubMedCrossRef
35.
Zurück zum Zitat Fischer EG, Carney JA, Anderson SR, Klatt EC, Lager DJ. An immunophenotypic comparison of metanephric metaplasia of Bowman capsular epithelium with metanephric adenoma, Wilms tumor, and renal development: a case report and review of the literature. Am J Clin Pathol. 2004;121(6):850–6.PubMedCrossRef Fischer EG, Carney JA, Anderson SR, Klatt EC, Lager DJ. An immunophenotypic comparison of metanephric metaplasia of Bowman capsular epithelium with metanephric adenoma, Wilms tumor, and renal development: a case report and review of the literature. Am J Clin Pathol. 2004;121(6):850–6.PubMedCrossRef
36.
Zurück zum Zitat Delahunt B, Farrant GJ, Bethwaite PB, Nacey JN, Lewis ME. Assessment of proliferative activity in Wilms’ tumour. Anal Cell Pathol. 1994;7(2):127–38.PubMed Delahunt B, Farrant GJ, Bethwaite PB, Nacey JN, Lewis ME. Assessment of proliferative activity in Wilms’ tumour. Anal Cell Pathol. 1994;7(2):127–38.PubMed
37.
Zurück zum Zitat Berrebi D, Leclerc J, Schleiermacher G, Zaccaria I, Boccon-Gibod L, Fabre M, et al. High cyclin E staining index in blastemal, stromal or epithelial cells is correlated with tumor aggressiveness in patients with nephroblastoma. PLoS One. 2008;3(5):e2216.PubMedCrossRef Berrebi D, Leclerc J, Schleiermacher G, Zaccaria I, Boccon-Gibod L, Fabre M, et al. High cyclin E staining index in blastemal, stromal or epithelial cells is correlated with tumor aggressiveness in patients with nephroblastoma. PLoS One. 2008;3(5):e2216.PubMedCrossRef
38.
Zurück zum Zitat Khine MM, Aung W, Sibbons PD, Howard CV, Clapham E, McGill F, et al. Analysis of relative proliferation rates of Wilms’ tumor components using proliferating cell nuclear antigen and MIB-1 (Ki-67 equivalent antigen) immunostaining and assessment of mitotic index. Lab Invest. 1994;70(1):125–9.PubMed Khine MM, Aung W, Sibbons PD, Howard CV, Clapham E, McGill F, et al. Analysis of relative proliferation rates of Wilms’ tumor components using proliferating cell nuclear antigen and MIB-1 (Ki-67 equivalent antigen) immunostaining and assessment of mitotic index. Lab Invest. 1994;70(1):125–9.PubMed
39.
Zurück zum Zitat Oh S, Song Y, Yim J, Kim TK. The Wilms’ tumor 1 tumor suppressor gene represses transcription of the human telomerase reverse transcriptase gene. J Biol Chem. 1999;274(52):37473–8.PubMedCrossRef Oh S, Song Y, Yim J, Kim TK. The Wilms’ tumor 1 tumor suppressor gene represses transcription of the human telomerase reverse transcriptase gene. J Biol Chem. 1999;274(52):37473–8.PubMedCrossRef
40.
Zurück zum Zitat Park JI, Venteicher AS, Hong JY, Choi J, Jun S, Shkreli M, et al. Telomerase modulates Wnt signalling by association with target gene chromatin. Nature. 2009;460(7251):66–72.PubMedCrossRef Park JI, Venteicher AS, Hong JY, Choi J, Jun S, Shkreli M, et al. Telomerase modulates Wnt signalling by association with target gene chromatin. Nature. 2009;460(7251):66–72.PubMedCrossRef
Metadaten
Titel
Telomerase reverse transcriptase catalytic subunit expression and proliferation index in Wilms tumor
verfasst von
Gulden Diniz
Safiye Aktas
Aysen Turedi
Gunyuz Temir
Ragip Ortac
Canan Vergin
Publikationsdatum
01.08.2011
Verlag
Springer Netherlands
Erschienen in
Tumor Biology / Ausgabe 4/2011
Print ISSN: 1010-4283
Elektronische ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-011-0178-1

Weitere Artikel der Ausgabe 4/2011

Tumor Biology 4/2011 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.